This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Mar;38(2):E5-6.

doi: 10.1503/jpn.120256.

Antidepressants and QTc prolongation

Raymond W Lam¹

Affiliations

PMID: 23422053
PMCID: PMC3581598
DOI: 10.1503/jpn.120256

Antidepressants and QTc prolongation

Raymond W Lam. J Psychiatry Neurosci. 2013 Mar.

. 2013 Mar;38(2):E5-6.

doi: 10.1503/jpn.120256.

Author

Raymond W Lam¹

Affiliation

¹ Department of Psychiatry, University of British Columbia,Vancouver, BC.

PMID: 23422053
PMCID: PMC3581598
DOI: 10.1503/jpn.120256

No abstract available

PubMed Disclaimer

Comment in

Escitalopram and QTc prolongation.
Hasnain M, Howland RH, Vieweg WV. Hasnain M, et al. J Psychiatry Neurosci. 2013 Jul;38(4):E11. doi: 10.1503/jpn.130055. J Psychiatry Neurosci. 2013. PMID: 23791140 Free PMC article. No abstract available.
Author response.
Lam RW. Lam RW. J Psychiatry Neurosci. 2013 Jul;38(4):E11-2. doi: 10.1503/jpn.130055. J Psychiatry Neurosci. 2013. PMID: 23791141 Free PMC article. No abstract available.

Similar articles

Escitalopram and QTc prolongation.
Hasnain M, Howland RH, Vieweg WV. Hasnain M, et al. J Psychiatry Neurosci. 2013 Jul;38(4):E11. doi: 10.1503/jpn.130055. J Psychiatry Neurosci. 2013. PMID: 23791140 Free PMC article. No abstract available.
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
Vieweg WV, Hasnain M, Howland RH, Hettema JM, Kogut C, Wood MA, Pandurangi AK. Vieweg WV, et al. Am J Med. 2012 Sep;125(9):859-68. doi: 10.1016/j.amjmed.2011.12.002. Epub 2012 Jun 27. Am J Med. 2012. PMID: 22748401 Review.
[Citalopram and Torsades de Pointes. A case report].
Meuleman C, Jourdain P, Bellorini M, Sadeg N, Loiret J, Guillard N, Thebault B, Funck F. Meuleman C, et al. Arch Mal Coeur Vaiss. 2001 Sep;94(9):1021-4. Arch Mal Coeur Vaiss. 2001. PMID: 11603066 French.
Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
Tseng PT, Lee Y, Lin YE, Lin PY. Tseng PT, et al. Gen Hosp Psychiatry. 2012 Mar-Apr;34(2):210.e13-5. doi: 10.1016/j.genhosppsych.2011.10.005. Epub 2011 Nov 30. Gen Hosp Psychiatry. 2012. PMID: 22133983 Review.
Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.
de Gregorio C, Morabito G, Cerrito M, Dattilo G, Oreto G. de Gregorio C, et al. Int J Cardiol. 2011 Apr 14;148(2):226-8. doi: 10.1016/j.ijcard.2009.05.060. Epub 2009 Jun 21. Int J Cardiol. 2011. PMID: 19540606 No abstract available.

See all similar articles

Cited by

Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder.
Adjei K, Adunlin G, Ali AA. Adjei K, et al. Healthcare (Basel). 2023 Mar 3;11(5):740. doi: 10.3390/healthcare11050740. Healthcare (Basel). 2023. PMID: 36900745 Free PMC article.
Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.
Pittenger C, Brennan BP, Koran L, Mathews CA, Nestadt G, Pato M, Phillips KA, Rodriguez CI, Simpson HB, Skapinakis P, Stein DJ, Storch EA. Pittenger C, et al. Psychiatry Res. 2021 Jun;300:113853. doi: 10.1016/j.psychres.2021.113853. Epub 2021 Mar 4. Psychiatry Res. 2021. PMID: 33975093 Free PMC article.
Physical Health and Drug Safety in Individuals with Schizophrenia.
Pringsheim T, Kelly M, Urness D, Teehan M, Ismail Z, Gardner D. Pringsheim T, et al. Can J Psychiatry. 2017 Sep;62(9):673-683. doi: 10.1177/0706743717719898. Epub 2017 Jul 18. Can J Psychiatry. 2017. PMID: 28718324 Free PMC article. Review.
Escitalopram and QTc prolongation.
Hasnain M, Howland RH, Vieweg WV. Hasnain M, et al. J Psychiatry Neurosci. 2013 Jul;38(4):E11. doi: 10.1503/jpn.130055. J Psychiatry Neurosci. 2013. PMID: 23791140 Free PMC article. No abstract available.
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review.
Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM, Kaye AM. Edinoff AN, et al. Neurol Int. 2021 Aug 5;13(3):387-401. doi: 10.3390/neurolint13030038. Neurol Int. 2021. PMID: 34449705 Free PMC article. Review.

See all "Cited by" articles

References

1. Alvarez PA, Pahissa J. QT alterations in psychopharmacology: proven candidates and suspects. Curr Drug Saf. 2010;5:97–104. - PubMed
1. Heist EK, Ruskin JN. Drug-induced proarrythmia and use of QTc prolonging agents: clues for clinicians. Heart Rhythm. 2005;2:S1–8. - PubMed
1. Stöllberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005;20:243–51. - PubMed
1. Barnes BJ, Hollands JM. Drug-induced arrhythmias. Crit Care Med. 2010;38(Suppl):S188–97. - PubMed
1. Drug lists by risk groups: drugs that prolong the QT interval and/or induce Torsades de Pointes. CredibleMeds. [accessed 2012 Apr. 11]. [a website of AZCERT, Inc] Available: wwwazcertorg/medical-pros/drug-lists/drug-listscfm.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov